Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
Senate Bill 2244
116th Congress(2019-2020)
METH Addiction Act
Introduced
Introduced
Introduced in Senate on Jul 24, 2019
Overview
Text
Introduced in Senate 
Jul 24, 2019
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in Senate(Jul 24, 2019)
Jul 24, 2019
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
S. 2244 (Introduced-in-Senate)


116th CONGRESS
1st Session
S. 2244


To amend the Controlled Substances Act to allow community addiction treatment facilities and community mental health facilities to register to dispense controlled substances through the practice of telemedicine, and for other purposes.

IN THE SENATE OF THE UNITED STATES

July 24, 2019

Mr. Roberts introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

A BILL

To amend the Controlled Substances Act to allow community addiction treatment facilities and community mental health facilities to register to dispense controlled substances through the practice of telemedicine, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Modernizing Eligible Treatment centers for Healing Addiction Act of 2019” or the “METH Addiction Act”.

SEC. 2. Registration of community addiction treatment facilities and community mental health facilities.

(a) Definitions.—Section 102 of the Controlled Substances Act (21 U.S.C. 802) is amended—

(1) in paragraph (54)(A), by striking clause (i) and inserting the following:

“(i) while the patient is being treated by, and physically located in—

“(I) a hospital or clinic registered under section 303(f); or

“(II) a community addiction treatment facility or community mental health facility registered under section 303(l); and”;

(2) by redesignating paragraph (58) as paragraph (59);

(3) by redesignating the second paragraph designated as paragraph (57) as paragraph (58);

(4) by moving paragraphs (57), (58) (as so redesignated), and (59) (as so redesignated) 2 ems to the left; and

(5) by adding at the end the following:

“(60) The term ‘community addiction treatment facility’ means an addiction treatment facility that, for the purpose of operating as an addiction treatment facility, is licensed, operated, authorized, or otherwise recognized by a State government.

“(61) The term ‘community mental health facility’ means a mental health facility that, for the purpose of operating as a mental health facility, is licensed, operated, authorized, or otherwise recognized by a State government.”.

(b) Registration.—Section 303 of the Controlled Substances Act (21 U.S.C. 823) is amended by adding at the end the following:

“(l) Community addiction treatment facilities and community mental health facilities.—

“(1) REGISTRATION.—The Attorney General may register community addiction treatment facilities and community mental health facilities to administer controlled substances through the practice of telemedicine.

“(2) DENIAL OF APPLICATIONS.—The Attorney General may deny an application for registration under paragraph (1) if the Attorney General determines that the registration would be inconsistent with the public interest after considering—

“(A) any recommendation by the licensing board or professional disciplinary authority of the State in which the applicant is located;

“(B) the experience of the applicant in treating patients;

“(C) any conviction of an employee of the applicant under Federal or State law relating to treatment of patients;

“(D) the compliance of the applicant with applicable Federal, State, or local laws relating to treatment of patients; and

“(E) any other conduct by the applicant that may threaten the health and safety of the public.”.

(c) Implementation plan.—Not later than 180 days after the date of enactment of this Act, the Attorney General shall notify Congress of the plan of the Department of Justice to implement the amendments made by this Act.

(d) Effective date.—The amendments made by this Act shall take effect on the date that is 180 days after the date on which the Attorney General notifies Congress under subsection (c).